MiR‐29b expression is associated with a dexmedetomidine‐mediated protective effect against oxygen‐glucose deprivation‐induced injury to SK‐N‐SH cells in vitro

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cell Biology International

• Publication date

  2018-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/cbin.10906PMID 29087603
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypoxia-Inducible Factor 1-Alpha

  2020cited by this paper
• Taxane-derived compounds protect SK-N-SH cells against oxidative stress injury induced by H2O2

  2017cited by this paper
• Hypoxia-inducible factor-1 alpha is involved in RIP-induced necroptosis caused by in vitro and in vivo ischemic brain injury

  2017cited by this paper
• Decreased miR‐146a expression in acute ischemic stroke directly targets the Fbxl10 mRNA and is involved in modulating apoptosis

  2017cited by this paper
• Serial changes in plasma ketone concentrations in patients with acute brain injury

  2017cited by this paper
• MicroRNA-146a down-regulation correlates with neuroprotection and targets pro-apoptotic genes in cerebral ischemic injury in vitro.

  2016cited by this paper
• Abstract 1107: miR-29b acts as an oncogene or tumor suppressor gene depending on the external stimulus

  2016cited by this paper
• MicroRNAs in cardiovascular disease: an introduction for clinicians

  2015cited by this paper
• Dexmedetomidine: A Review of a Newer Sedative in Dentistry.

  2015influential reference
• CONTINUING EDUCATION IN HONOR OF NORMAN TRIEGER, DMD, MD Alpha-2 Adrenergic Receptor Agonists: A Review of Current Clinical Applications

  2015cited by this paper
• Ischemia-Reperfusion Injury in Stroke

  2013cited by this paper
• Sugar for the brain: the role of glucose in physiological and pathological brain function.

  2013cited by this paper
• Pathophysiologic Cascades in Ischemic Stroke

  2012cited by this paper
• MicroRNA-mediated posttranscriptional mechanisms of gene expression in proliferating and quiescent cancer cells

  2012cited by this paper
• Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury

  2012cited by this paper
• miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis.

  2011cited by this paper
• Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury

  2011influential reference
• Effects of dexmedetomidine on the release of glial cell line-derived neurotrophic factor from rat astrocyte cells.

  2011cited by this paper
• Temporal Differences in MicroRNA Expression Patterns in Astrocytes and Neurons after Ischemic Injury

  2011cited by this paper
• miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia.

  2010cited by this paper
• miR-29 miRNAs activate p53 by targeting p85α and CDC42

  2009cited by this paper
• MicroRNA 29b functions in acute myeloid leukemia.

  2009cited by this paper
• The influence of dexmedetomidine on ischemic rat hippocampus.

  2008cited by this paper
• The Effects of Dexmedetomidine on Perinatal Excitotoxic Brain Injury are Mediated by the α2A-Adrenoceptor Subtype

  2006cited by this paper
• Time window characteristics of cultured rat hippocampal neurons subjected to ischemia and reperfusion.

  2005cited by this paper
• Dexmedetomidine-Induced Stimulation of Glutamine Oxidation in Astrocytes: A Possible Mechanism for its Neuroprotective Activity

  2000cited by this paper
• Alpha‐2 and imidazoline receptor agonistsTheir pharmacology and therapeutic role

  1999cited by this paper
• Neuroprotective Effects of Dexmedetomidine in the Gerbil Hippocampus after Transient Global Ischemia

  1997cited by this paper
• Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia.

  1993cited by this paper
• Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole.

  1991cited by this paper
• Transient Focal Cerebral Ischaemia

  1963cited by this paper
• International Journal of Molecular Sciences Micrornas: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases

  year unknowncited by this paper

• The Effects of Dexmedetomidine on Injury Induced by Oxygen and Glucose Deprivation/Reperfusion in a Neuroblastoma Cell Line of Mouse Origin

  2025influential citation
• Progress on the Mechanisms and Neuroprotective Benefits of Dexmedetomidine in Brain Diseases

  2024cites this paper
• MicroRNA-323-5p Involved in Dexmedetomidine Preconditioning Impart Neuroprotection

  2023cites this paper
• Dexmedetomidine suppresses hippocampal astrocyte pyroptosis in cerebral hypoxic-ischemic neonatal rats by upregulating microRNA-148a-3p to inactivate the STAT/JMJD3 axis.

  2023cites this paper
• Dexmedetomidine Protects Cerebellar Neurons against Hyperoxia-Induced Oxidative Stress and Apoptosis in the Juvenile Rat

  2023cites this paper
• The Role of miRNAs in Dexmedetomidine’s Neuroprotective Effects against Brain Disorders

  2022cites this paper
• The neuroprotective effect of dexmedetomidine and its mechanism

  2022cites this paper
• Mechanism of dexmedetomidine regulating osteogenesis-angiogenesis coupling through the miR-361-5p/VEGFA axis in postmenopausal osteoporosis.

  2021cites this paper
• Dexmedetomidine post-conditioning ameliorates long-term neurological outcomes after neonatal hypoxic ischemia: The role of autophagy.

  2021cites this paper
• Dexmedetomidine exerts a protective effect on ischemic brain injury by inhibiting the P2X7R/NLRP3/Caspase-1 signaling pathway.

  2021cites this paper
• The potential role of dexmedetomidine on neuroprotection and its possible mechanisms: Evidence from in vitro and in vivo studies

  2021cites this paper
• Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.

  2020cites this paper
• Dexmedetomidine‐up‐regulated microRNA‐381 exerts anti‐inflammatory effects in rats with cerebral ischaemic injury via the transcriptional factor IRF4

  2020cites this paper
• The administration of dexmedetomidine changes microRNA expression profiling of rat hearts.

  2019cites this paper
• Identification of Candidate Genes and Pathways in Dexmedetomidine-Induced Cardioprotection in the Rat Heart by Bioinformatics Analysis

  2019cites this paper
• Oxidative Stress Regulated Iron Regulatory Protein IRP2 Through FBXL5-Mediated Ubiquitination-Proteasome Way in SH-SY5Y Cells

  2019cites this paper
• MicroRNA-29b-3p aggravates 1,2-dichloroethane-induced brain edema by targeting aquaporin 4 in Sprague-Dawley rats and CD-1 mice.

  2019cites this paper
• microRNA-128 enhances neuroprotective effects of dexmedetomidine on neonatal mice with hypoxic-ischemic brain damage by targeting WNT1.

  2019cites this paper
• Dexmedetomidine protects liver cell line L-02 from oxygen-glucose deprivation-induced injury by down-regulation of microRNA-711.

  2018cites this paper
• Surgery, neuroinflammation and cognitive impairment

  2018cites this paper